Product NDC: | 0409-2028 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | MORPHINE SULFATE |
Active Ingredient(s): | .5 mg/mL & nbsp; MORPHINE SULFATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2028 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019917 |
Marketing Category: | NDA |
Start Marketing Date: | 19921030 |
Package NDC: | 0409-2028-02 |
Package Description: | 10 CARTON in 1 CONTAINER (0409-2028-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0409-2028-02 |
Proprietary Name | Morphine Sulfate |
Package Description | 10 CARTON in 1 CONTAINER (0409-2028-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0409-2028 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MORPHINE SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19921030 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | MORPHINE SULFATE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |